- Home
- IMUX vs MOB Comparison
IMUX vs MOB Comparison
Compare IMUX & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | MOB |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Israel |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 84.0M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMUX | MOB |
|---|---|---|
| Price | $1.19 | $5.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $4.25 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 2.9M | 236.2K |
| Earning Date | 02-26-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $94.62 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $1.31 |
| 52 Week High | $1.51 | $11.01 |
Technical Indicators
Market Signals| Indicator | IMUX | MOB |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 47.63 |
| Support Level | $0.64 | $5.41 |
| Resistance Level | $1.51 | $6.51 |
| Average True Range (ATR) | 0.12 | 0.67 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 27.78 | 32.94 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.